Blood Disorder News and Research

RSS
Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Alexion Pharmaceuticals plans to launch Soliris in Japan for patients with PNH

Americans who travel abroad could use extra health coverage

Americans who travel abroad could use extra health coverage

New study reinforces urgent need for life-saving vaccines in Africa

New study reinforces urgent need for life-saving vaccines in Africa

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Study: Lower blood oxygen levels can lead to heart abnormalities in children with sickle cell disease

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris

Alexion Pharmaceuticals reports total revenues of $117.6M from net product sales of Soliris

Alexion Pharmaceuticals completes enrollment in Soliris clinical studies for aHUS

Alexion Pharmaceuticals completes enrollment in Soliris clinical studies for aHUS

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Study provides benchmark data to evaluate quality of management of sickle cell disease

Study provides benchmark data to evaluate quality of management of sickle cell disease

Sickle cell disease: Rehospitalization rates high

Sickle cell disease: Rehospitalization rates high

Rebirth of the cursed drug Thalidomide

Rebirth of the cursed drug Thalidomide

Genetic instability in people with Fanconi anemia: New proteins in FA DNA repair pathway may help explain

Genetic instability in people with Fanconi anemia: New proteins in FA DNA repair pathway may help explain

Ligand Pharmaceuticals: GSK granted marketing authorization from EC for Revolade

Ligand Pharmaceuticals: GSK granted marketing authorization from EC for Revolade

TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for breast cancer study

TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for breast cancer study

Side-Out Foundation sponsors new advanced breast cancer clinical trial

Side-Out Foundation sponsors new advanced breast cancer clinical trial

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Alexion Pharmaceuticals announces financial results for quarter and year ended December 31, 2009

Alexion Pharmaceuticals announces financial results for quarter and year ended December 31, 2009

Statins may protect SCD children from pneumococcal infection

Statins may protect SCD children from pneumococcal infection